Gene polymorphisms of interleukins 1 and 10 in infectious and autoimmune diseases

Annals of Medicine

Volumn 30, Issue 5, 1998, Pages 469-473

  Hurme, Mikko ^a   Lahdenpohja, Nina ^a   Santtila, Sari ^a  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

Author keywords

Gene polymorphism; Inflammation; Interleukin 1; Interleukin 10

Indexed keywords

COLONY STIMULATING FACTOR; CYTOKINE; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 6; TUMOR NECROSIS FACTOR;

ARTICLE; AUTOIMMUNE DISEASE; DNA POLYMORPHISM; HEMATOPOIESIS; HUMAN; IMMUNE RESPONSE; INFECTION; PRIORITY JOURNAL;

EID: 0031756128     PISSN: 07853890     EISSN: None     Source Type: Journal    
DOI: 10.3109/07853899809002488     Document Type: Article

References (41)

1. Abel L, Dessein AJ. The impact of host genetics on susceptibility to human infectious diseases. Curr Opin Immunol 1997; 9: 509-16.
2. Zinkernagel RM, Doherty PC. The discovery of MHC restriction. Immunol Today 1997; 18: 14-6.
3. Thursz MR, Thomas HC, Greenwood BM, Hill AVS. Heterozygote advantage for HLA class-II type in hepatitis B virus infection. Nat Genet 1997; 17: 11-2.
4. Dinarello CA. Biologic basis for interleukin-1 in disease. Blood 1996; 87: 2095-147.
5. Lennard AC. Interleukin-1 receptor antagonist. Crit Rev Immunol 1995; 15: 77-105.
6. Mossman TR. Properties and functions on interleukin-10. Adv Immunol 1994; 56: 1-26.
7. Papanicolau DA. The pathophysiological roles of interleukin-6 in human disease. Ann Intern Med 1998; 128: 127-37.
8. Wilson AG, di Giovine FS, Duff GW. Genetics of tumor necrosis factor-α in autoimmune, infectious, and neoplastic diseases. J Inflamm 1995; 45: 1-12.
9. Takashima K, Takeda K, Matsumoto T, Iizava Y, Nakao M, Yamaguchi K. Role of tumor necrosis factor alpha in pathogenesis of pneumococcal pneumonia in mice. Infect Immun 1997; 65: 257-60.
10. Hack CE, Aarden LA, Thijs LG. Role of cytokines in sepsis. Adv Immunol 1997; 66: 101-95.
11. Eigler A, Sinha B, Hartman G, Endres S. Taming TNF: strategies to restrain this proinflammatory cytokine. Immunol Today 1997; 18: 487-92.
12. Waage A, Haltensen T, Espevik T. Association between tumor necrosis factor in serum and fatal outcome in patients with meningococcal sepsis. Lancet 1987; 1: 355-7.
13. McDowell TJ, Symons JA, Ploski R, Forre O, Duff GW. A genetic association between juvenile rheumatoid arthritis and a novel interleukin-1α polymorphism. Arthritis Rheum 1995; 38: 221-8.
14. Bailly S, di Giovine FS, Duff GW. Polymorphic tandem repeat region in interleukin-aα intron 6. Hum Genet 1993; 91: 85-6.
15. di Giovine FS, Taksh E, Blakemore AIF, Duff GW. Single base polymorphism at -511 in the human interleukin-1β gene (IL-1β). Hum Mol Genet 1992; 1: 450.
16. Pociot F, Molvig J, Wogensen L, Worsaae H, Nerup J. A TaqI polymorphism in the human interleukin-1β (IL-1β) gene correlates with IL-1β secretion in vitro. Eur J Clin Invest 1992; 22: 396-402.
17. Tarlow JK, Blakemore AIF, Lennard A, et al. Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat. Hum Genet 1993; 91: 403-4.
18. Santtila S, Savinainen K, Hurme M. Presence of the IL-1RA allele 2 (IL1RN*2) is associated with enhanced IL-1β production in vitro. Scand J Immunol 1998; 47: 195-8.
19. Hurme M, Santtila S. IL-1 receptor antagonist (IL-1Ra) plasma levels are co-ordinately regulated by both IL-1Ra and IL-1β genes. Eur J Immunol 1998; 28: 2598-602.
20. Danis VA, Millington M, Hyland VJ, Grennan D. Cytokine production by normal human monocytes: inter-subject variation and relationship to an IL-1 receptor antagonist (IL-1Ra) gene polymorphism. Clin Exp Immunol 1995; 99: 303-10.
21. Mansfield J C, Holden H, Tarlow JK, et al. Novel genetic association between ulcerative colitis and the antiinflammatory cytokine interleukin-1 receptor antagonist. Gastroenterology 1994; 106: 637-42.
22. Hacker UT, Gomolka M, Keller E, et al. Lack of association between an interleukin-1 receptor antagonist gene polymorphism and ulcerative colitis. Gut 1997; 40, 623-7.
23. Tarlow JK, Clay FE, Cork MJ, et al. Severity of alopecia areata is associated with a polymorphism in the interleukin-1 receptor antagonist gene. J Invest Dermatol 1994; 103: 387-90.
24. Blakemore AIF, Tarlow JK, Cork MJ, Gordon C, Emery P, Duff GW. Interleukin-1 receptor antagonist gene polymorphism as a disease severity factor in systemic lupus erythematosus. Arthritis Rheum 1994; 37: 1380-5.
25. Danis VA, Millington M, Huang Q, Hyland V, Grennan, D. Lack of association between an interleukin-1 receptor antagonist gene polymorphism and systemic lupus erythematosus. Dis Markers 1994; 12: 135-9.
26. Clay FE, Cork MJ, Tarlow JK, et al. Interleukin 1 receptor antagonist gene polymorphism association with lichen sclerosus. Hum Genet 1994; 94: 407-10.
27. Blakemore AIF, Watson PF, Weetman AP, Duff GW. Association of Graves' disease with an allele of the interleukin-1 receptor antagonist gene. J Clin Endocrinol Metab 1995; 80: 111-5.
28. Crusius JBA, Pena AS, van Oosten BW, et al. Interleukin-1 receptor antagonist gene polymorphism and multiple sclerosis. Lancet 1995; 346: 979-80.
29. Huang W-X, He B, Hillert J. An interleukin 1-receptor-antagonist gene polymorphism is not associated with multiple sclerosis. J Neuroimmunol 1996; 67: 143-4.
30. Blakemore AIF, Cox A, Gonzales AM, et al. Interleukin-1 receptor antagonist allele (IL1RN*2) associated with nephropathy in diabetes mellitus. Hum Genet 1996; 97: 369-74.
31. Tarnow L, Pociot F, Hansen PM, et al. Polymorphisms in the interleukin-1 gene cluster do not contribute to the genetic susceptibility of diabetic nephropathy in Caucasian patients with IDDM. Diabetes 1997; 46: 1075-6.
32. Bioque G, Crusius JBA, Koutroubakis I, et al. Allelic polymorphism in IL-1β and IL-1 receptor antagonist (IL-1Ra) genes in inflammatory bowel diseases. Clin Exp Immunol 1995; 102: 379-83.
33. Hercsbach D, Alizadeh M, Dabadie A, et al. Significance of interleukin-1β and interleukin-1 receptor antagonist genetic polymorphism in inflammatory bowel diseases. Am J Gastroenterol 1997; 92: 1164-9.
34. Kornman KS, Crane A, Wang HY, et al. The interleukin-1 genotype as a severity factor in adult periodontal disease. J Clin Periodontol 1997; 24: 72-7.
35. Hurme M, Helminen M. Polymorphism of the IL-1 gene complex in Epstein-Barr virus seronegative and seropositive adult blood donors. Scand J Immunol (in press).
36. Eskdale J, Kube D, Tesch H, Gallagher G. Mapping of the human IL-10 gene and further characterization of the 5′ flanking sequence. Immunogenetics 1997; 46: 120-8.
37. Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnot PJ, Hutchinson IV. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogen 1997; 24: 1-8.
38. Eskdale J, Wordsworth P, Bowman S, Field M, Gallagher G. Association between polymorphisms at the human IL-10 locus and systemic lupus erythematosus. Tissue Antigens 1997; 49: 635-9.
39. Lazarus M, Hajcer AH, Turner D, et al. Genetic variation in the interleukin 10 gene promoter and systemic lupus erythematosus. J Rheumatol 1997; 24: 2314-7.
40. Hajeer AH, Lazarus M, Turner D, et al. IL-10 gene promoter polymorphism in rheumatoid arthritis. Scand J Rheumatol 1998; 27: 142-5.
41. Westendorp RGJ, Langermans JAM, Huizinga TWJ, et al. Genetic influence on cytokine production and fatal meningococcal disease. Lancet 1997; 349: 170-3.